Household & Personal Products

Discover why investors are watching Kenvue’s upcoming earnings—key revenue, margin and dividend insights that could shape its 2026 outlook.

caring brands, inc. secures exclusive global license for dermatological product Emesyl, expanding its wellness portfolio and boosting market presence.

WD‑40 Co. Q1 2026 earnings preview: modest EPS rise, steady 1% revenue growth, and 4.8% FY increase amid brand resilience and market‑share expansion.

Olaplex Holdings (OLPX) pivots with a new strategy amid negative earnings, seeking to boost profits and regain investor confidence in the hair‑care market.

Upexi Inc. shifts its Solana treasury to a risk‑adjusted high‑yield strategy, boosting returns and operational flexibility while supporting consumer‑brand growth.

Herbalife’s stock, valued at $12.91, shows a conservative 4.15 P/E ratio amid a $10.13 52‑week range, highlighting growth potential and valuation questions for investors.

Big Tree Cloud faces Nasdaq’s 50‑million‑USD MVLS challenge, with a 180‑day window to raise capital and boost liquidity before a possible delisting.

Upexi Inc. (UPEXI) is reshaping eCommerce with SaaS‑powered ad tech and data‑driven cross‑selling, aiming to cut acquisition costs and scale brands, despite its current earnings volatility and a $106 million market cap.

How Kenvue’s Tylenol‑autism lawsuit threatens its stock and strategy – read the latest risk analysis.

Care Brands Inc. secures worldwide rights to produce and distribute Itonis’s drug Emesyl, expanding its portfolio into pharma and boosting future revenue potential.